Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OZ Biosciences : Capture and Concentrate Virus

Published: Monday, November 19, 2012
Last Updated: Monday, November 19, 2012
Bookmark and Share
OZ Biosciences SAS, specialized in the development of innovative transfection technologies is delighted to announce the launching of new products Mag4C Kits.

Mag4C Kits are specifically developed for capturing, concentrating and storing viruses. These kits are composed of 3 reagents allowing Magnetic Capture/Concentration, Elution and Conservation of viruses.

"We continuously improve our core technology", explains Olivier Zelphati, CEO of OZ Biosciences. Indeed, Mag4C Kits are new specific superparamagnetic nanoparticles formulation evolved from our Magnetofection™ Technology.

Mag4C magnetic nanoparticles capture by electrostatic and hydrophobic interactions viruses in culture medium with 80-99 % efficiency. Simple, rapid and ready to use this product allows concentrating virus by magnetic capture in 30-45 minutes. In this way, ultracentrifugation, precipitation and chemicals are avoided. Once captured onto magnetic beads, viruses can be:

(1) Concentrated and stored with the Conservation Buffer or directly used for cell culture, molecular biology or other assays.

(2) Concentrated, eluted from the magnetic beads with the Elution Buffer and stored with the Conservation Buffer or used for various assays.

Moreover, these kits contain particular conservation buffers that improve virus stability upon storage conditions.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
Paper Filter Can Remove Viruses from Water
A new paper filter can purify water from viruses, even the most difficult and contagious.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
New HIV Vaccine Target Discovered
NIH-Led team have discovered a new vaccine target site on HIV.
Mimicking Evolution to Create Novel Proteins
A study by researchers in the Kuhlman lab offers a new route to design the 'cellular machines' needed to understand and battle diseases.
Antibody Therapy Opens Door to Potential New Treatment for HIV
Researchers at Rockefeller University show how a broadly neutralizing antibody could be used to help fight HIV.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!